Efficacy and Safety of XRP0038/NV1FGF in Critical Limb Ischemia Patients With Skin Lesions - Related Studies

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	No Study Results Posted


	Related Studies

Efficacy and Safety of XRP0038/NV1FGF in Critical Limb Ischemia Patients With Skin Lesions (TAMARIS)

This study is currently recruiting participants.

Study NCT00566657. Last updated on November 14, 2008. Information provided by Sanofi-Aventis

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Peripheral Vascular Diseases

2	Additional conditions recognized in this trial
		Ischemia
		Vascular Diseases

3	More general conditions related to this trial
		Cardiovascular Diseases
		Pathologic Processes

4	Interventions listed in this trial
		XRP0038/NV1FGF
		placebo

5	Sponsors listed in this trial
		Sanofi-Aventis